{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:17:49Z","timestamp":1788322669569,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"1-3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.jad.2012.05.006","type":"journal-article","created":{"date-parts":[[2012,9,11]],"date-time":"2012-09-11T04:46:34Z","timestamp":1347338794000},"page":"257-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["A randomized, double-blind, placebo-controlled trial of citicoline for bipolar and unipolar depression and methamphetamine dependence"],"prefix":"10.1016","volume":"143","author":[{"given":"E. Sherwood","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Gabrielson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2012.05.006_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11064-004-9681-8","article-title":"Cytidine 5\u2019-diphosphocholine (CDP-choline) in stroke and other CNS disorders","volume":"30","author":"Adibhatla","year":"2005","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.jad.2012.05.006_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/13854049108403297","article-title":"The Hopkins verbal learning test: development of a new memory test with six equivalent norms","volume":"5","author":"Brandt","year":"1991","journal-title":"The Clinical Neuropsychologist"},{"key":"10.1016\/j.jad.2012.05.006_bib3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/JCP.0b013e31814db4c4","article-title":"A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence","volume":"27","author":"Brown","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2012.05.006_bib4","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0006-3223(01)01344-0","article-title":"Antidepressant-like effects of cytidine in the forced swim test in rats","volume":"51","author":"Carlezon","year":"2002","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jad.2012.05.006_bib5","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1161\/01.STR.30.12.2592","article-title":"A randomized efficacy trial of citicoline in patients with acute ischemic stroke","volume":"30","author":"Clark","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.jad.2012.05.006_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/neu.1997.14.161","article-title":"Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release","volume":"14","author":"Dixon","year":"1997","journal-title":"Journal of Neurotrauma"},{"key":"10.1016\/j.jad.2012.05.006_bib7","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/sj.npp.1301481","article-title":"Bupropion for the treatment of methamphetamine dependence","volume":"33","author":"Elkashef","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2012.05.006_bib8","doi-asserted-by":"crossref","unstructured":"Fioravanti, M., Yanagi, M., 2005. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database of Systematic Reviews, CD000269.","DOI":"10.1002\/14651858.CD000269.pub3"},{"key":"10.1016\/j.jad.2012.05.006_bib9","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders. Biometrics Research Department, New York State Psychiatric Institute, Department of Psychiatry","author":"First","year":"1995"},{"key":"10.1016\/j.jad.2012.05.006_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1465-3362.2009.00081.x","article-title":"Psychopathology in methamphetamine-dependent adults 3 years after treatment","volume":"29","author":"Glasner-Edwards","year":"2010","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jad.2012.05.006_bib11","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1176\/appi.ajp.2008.08020304","article-title":"Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial","volume":"165","author":"Jayaram-Lindstrom","year":"2008","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.05.006_bib12","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1038\/sj.npp.1301572","article-title":"Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence","volume":"33","author":"Jayaram-Lindstrom","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2012.05.006_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145707007778","article-title":"A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence","volume":"11","author":"Johnson","year":"2008","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2012.05.006_bib14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1360-0443.2009.02717.x","article-title":"Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence","volume":"105","author":"Longo","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.jad.2012.05.006_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1037\/a0017336","article-title":"Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis","volume":"24","author":"McClintock","year":"2010","journal-title":"Neuropsychology"},{"key":"10.1016\/j.jad.2012.05.006_bib16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jad.2008.04.016","article-title":"Attrition factors in clinical trials of comorbid bipolar and substance-related disorders","volume":"112","author":"Nomamiukor","year":"2009","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2012.05.006_bib17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.psc.2005.02.005","article-title":"Cognition in bipolar disorder","volume":"28","author":"Osuji","year":"2005","journal-title":"Psychiatric Clinics of North America"},{"key":"10.1016\/j.jad.2012.05.006_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0306-3623(90)90598-G","article-title":"Changes in brain biogenic monoamines induced by the nootropic drugs adafenoxate and meclofenoxate and by citicholine (experiments on rats)","volume":"21","author":"Petkov","year":"1990","journal-title":"General Pharmacology"},{"key":"10.1016\/j.jad.2012.05.006_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0740-5472(02)00256-8","article-title":"Treatment of methamphetamine use disorders: an update","volume":"23","author":"Rawson","year":"2002","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jad.2012.05.006_bib20","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study","volume":"264","author":"Regier","year":"1990","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jad.2012.05.006_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s002130050871","article-title":"Short-term treatment with citicoline (CDP-choline) attenuates some measures of craving in cocaine-dependent subjects: a preliminary report","volume":"142","author":"Renshaw","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jad.2012.05.006_bib22","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1176\/appi.ajp.163.11.1993","article-title":"Contingency management for the treatment of methamphetamine use disorders","volume":"163","author":"Roll","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.05.006_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0033291700035558","article-title":"The Inventory of Depressive Symptomatology (IDS): psychometric properties","volume":"26","author":"Rush","year":"1996","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.jad.2012.05.006_bib24","first-page":"513","article-title":"Clinical evaluation of CDP-choline (Nicholin): efficacy As antidepressant treatment","volume":"18","author":"Salvadorini","year":"1975","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"key":"10.1016\/j.jad.2012.05.006_bib25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1360-0443.2008.02437.x","article-title":"A double-blind, placebo-controlled trial of modafinil (200mg\/day) for methamphetamine dependence","volume":"104","author":"Shearer","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.jad.2012.05.006_bib26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1360-0443.2009.02791.x","article-title":"Cognitive enhancement as a pharmacotherapy target for stimulant addiction","volume":"105","author":"Sofuoglu","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.jad.2012.05.006_bib27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0006-3223(95)00423-8","article-title":"Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients","volume":"40","author":"Stoll","year":"1996","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jad.2012.05.006_bib28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.164.1.160","article-title":"A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence","volume":"164","author":"Tiihonen","year":"2007","journal-title":"American Journal of Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503271200290X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503271200290X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T18:10:42Z","timestamp":1562177442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016503271200290X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":28,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S016503271200290X"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2012.05.006","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized, double-blind, placebo-controlled trial of citicoline for bipolar and unipolar depression and methamphetamine dependence","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2012.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}